Literature DB >> 29280019

Impact of short-term cycle ergometer training on quality of life, cognition and depressive symptomatology in multiple sclerosis patients: a pilot study.

Alison Barry1, Owen Cronin2, Aisling M Ryan3, Brian Sweeney3, Orna O'Toole4, Andrew P Allen5, Gerard Clarke5, Ken D O'Halloran1, Eric J Downer6.   

Abstract

In this pilot study, we investigate whether a routine cycle ergometry training programme has therapeutic potential in individuals with multiple sclerosis (MS) by improving quality of life (QOL) and depressive symptomatology, while ameliorating cognitive disturbances. Healthy volunteers and MS patients cycled for 30 min at 65-75% age-predicted maximal heart rate on a recumbent ergometer, with this session repeated twice a week for 8 weeks. QOL, depressive symptomatology and cognitive function were assessed pre- and post-exercise using the MS Quality of Life-54 (MSQOL-54) questionnaire, 16-item Quick Inventory of Depressive Symptomatology (QIDS-SR16) questionnaire and the Cambridge Neuropsychological Test Automated Battery (CANTAB), respectively. We determined that QOL was lower in MS patients, compared to healthy subjects, with a reduction in physical and mental health summary scores observed. Exercise improved both physical and mental health scores in MS patients. In support of this, exercise was shown to reduce depressive symptomatology in MS patients. Exercise was also associated with an improvement in visual sustained attention, executive function/cognitive flexibility and hippocampal-dependent visuospatial memory in patients. Overall, this study identifies a short-term exercise programme that improves physical and mental health, while reducing depressive symptomatology and cognitive dysfunction in MS.

Entities:  

Keywords:  Cognition; Depression; Exercise; Multiple sclerosis; Quality of life

Mesh:

Substances:

Year:  2017        PMID: 29280019     DOI: 10.1007/s10072-017-3230-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

1.  Combined upper limb and breathing exercise programme for pain management in ambulatory and non-ambulatory multiple sclerosis individuals: part II analyses from feasibility study.

Authors:  Tanja Grubić Kezele; Matea Babić; Tamara Kauzlarić-Živković; Tamara Gulić
Journal:  Neurol Sci       Date:  2019-08-17       Impact factor: 3.307

2.  Exploring the feasibility of a mild and short 4-week combined upper limb and breathing exercise program as a possible home base program to decrease fatigue and improve quality of life in ambulatory and non-ambulatory multiple sclerosis individuals.

Authors:  Tanja Grubić Kezele; Matea Babić; Dinko Štimac
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

3.  Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial.

Authors:  Lisa Baquet; Helge Hasselmann; Stefan Patra; Jan-Patrick Stellmann; Eik Vettorazzi; Andreas K Engel; Sina Cathérine Rosenkranz; Jana Poettgen; Stefan Michael Gold; Karl-Heinz Schulz; Christoph Heesen
Journal:  PeerJ       Date:  2018-12-12       Impact factor: 2.984

Review 4.  Physical exercise effects on the brain during COVID-19 pandemic: links between mental and cardiovascular health.

Authors:  Ricardo Augusto Leoni De Sousa; Alex Cleber Improta-Caria; Roque Aras-Júnior; Edilamar Menezes de Oliveira; Úrsula Paula Reno Soci; Ricardo Cardoso Cassilhas
Journal:  Neurol Sci       Date:  2021-01-25       Impact factor: 3.830

Review 5.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

Authors:  John DeLuca; Nancy D Chiaravalloti; Brian M Sandroff
Journal:  Nat Rev Neurol       Date:  2020-05-05       Impact factor: 42.937

6.  Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis.

Authors:  John-Mark Fitzpatrick; Becky Hackett; Lisa Costelloe; William Hind; Eric J Downer
Journal:  Molecules       Date:  2022-03-08       Impact factor: 4.411

7.  The subtleties of cognitive decline in multiple sclerosis: an exploratory study using hierarchichal cluster analysis of CANTAB results.

Authors:  Hideraldo Luis Souza Cabeça; Luciano Chaves Rocha; Amanda Ferreira Sabbá; Alessandra Mendonça Tomás; Natali Valim Oliver Bento-Torres; Daniel Clive Anthony; Cristovam Wanderley Picanço Diniz
Journal:  BMC Neurol       Date:  2018-09-10       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.